CS logo
small CS logo
LKH Leoben

Leoben, Austria
Hospital in Leoben
Vordernberger Str. 42, 8700 Leoben

About LKH Leoben


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Celgene
4
Arbeitsgemeinschaft medikamentoese Tumortherapie
3
Boehringer Ingelheim
3
Alliance Foundation Trials, LLC.
1
Amgen
1
Austrian Forum Against Cancer
1
Canadian Cancer Trials Group
1
Central European Cooperative Oncology Group
1
Daniela Kandioler
1
GERCOR - Multidisciplinary Oncology Cooperative Group
1
Gesellschaft fur Padiatrische Onkologie und Hamatologie - Germany
1
Total Rows: 19

Clinical Trials at LKH Leoben


During the past decade, LKH Leoben conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 4 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years2200442222111100000000220011Started TrialsCompleted Trails20152016201720182019202020210246
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Surgery in Treating Patients With Neuroblastoma
1994-12-01
Unknown status
210
Observation of Young Patients Who Are Undergoing Surgery for Craniopharyngioma
2001-05-01
2009-09-01
Completed
120
Optimized Chemotherapy Followed by Maintenance With Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Colorectal Cancer That Cannot be Removed by Surgery (DREAM)
2005-05-01
Completed
700
Bortezomib-Dexamethasone-Doxorubicin-Study
2006-02-01
2009-11-01
Completed
72
Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic Leukemia
2000-07-01
2012-01-01
Completed
4,559
p53-Adjusted Neoadjuvant Chemotherapy for Potentially Resectable Esophageal Cancer
2007-06-01
2012-12-01
Completed
170
2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab
2008-04-01
2014-12-01
Completed
564
Panther: A Study Comparing Biweekly and Tailored EC-T Versus Three Weekly FEC-T in Breast Cancer Patients
2007-02-01
2022-01-01
Unknown status
2,017

Rows per page:

1–26 of 26

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "LKH Leoben" #1 sponsor was "Celgene" with 4 trials, followed by "Arbeitsgemeinschaft medikamentoese Tumortherapie" with 3 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored, "Alliance Foundation Trials, LLC." with 1 trials sponsored and "Amgen" with 1 trials sponsored. Other sponsors include 9 different institutions and companies that sponsored additional 19 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "LKH Leoben" #1 collaborator was "Amgen" with 2 trials as a collaborator, "Austrian Breast & Colorectal Cancer Study Group" with 2 trials as a collaborator, "Breast International Group" with 2 trials as a collaborator, "Medical University of Vienna" with 2 trials as a collaborator and "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator. Other collaborators include 43 different institutions and companies that were collaborators in the rest 53 trials.
Created with Highcharts 11.1.0Top Leading SponsorsCelgene: 4Celgene: 4ArbeitsgemeinschaftmedikamentoeseTumortherapie: 3ArbeitsgemeinschaftmedikamentoeseTumortherapie: 3Boehringer Ingelheim: 3Boehringer Ingelheim: 3Alliance FoundationTrials, LLC.: 1Alliance FoundationTrials, LLC.: 1Amgen: 1Amgen: 1Austrian Forum AgainstCancer: 1Austrian Forum AgainstCancer: 1Canadian Cancer Trials Group: 1Canadian Cancer Trials Group: 1Central EuropeanCooperative OncologyGroup: 1Central EuropeanCooperative OncologyGroup: 1Daniela Kandioler: 1Daniela Kandioler: 1GERCOR -MultidisciplinaryOncology CooperativeGroup: 1GERCOR -MultidisciplinaryOncology CooperativeGroup: 1

Created with Highcharts 11.1.0Top CollaboratorsAmgen: 2Amgen: 2Austrian Breast &Colorectal Cancer StudyGroup: 2Austrian Breast &Colorectal Cancer StudyGroup: 2Breast International Group: 2Breast International Group: 2Medical University of Vienna: 2Medical University of Vienna: 2ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1ArbeitsgemeinschaftGynaekologischeOnkologieStudiengruppeOvarialkarzinomGermany: 1ArbeitsgemeinschaftGynaekologischeOnkologieStudiengruppeOvarialkarzinomGermany: 1Assign DataManagement andBiostatistics GmbH: 1Assign DataManagement andBiostatistics GmbH: 1Austrian Society OfSurgical Oncology: 1Austrian Society OfSurgical Oncology: 1Barmherzige Brüder Vienna: 1Barmherzige Brüder Vienna: 1Belgium GynecologicOncology Group: 1Belgium GynecologicOncology Group: 1

Clinical Trials Conditions at LKH Leoben


According to Clinical.Site data, the most researched conditions in "LKH Leoben" are "Multiple Myeloma" (5 trials), "Breast Cancer" (2 trials), "Metastatic Breast Cancer" (2 trials), "Acute Myeloid Leukemia" (1 trials) and "Advanced Breast Cancer" (1 trials). Many other conditions were trialed in "LKH Leoben" in a lesser frequency.

Clinical Trials Intervention Types at LKH Leoben


Most popular intervention types in "LKH Leoben" are "Drug" (18 trials), "Procedure" (3 trials), "Biological" (2 trials), "Other" (2 trials) and "Radiation" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (3 trials), "Lenalidomide" (2 trials), "radiation therapy" (2 trials), "5-Fluoruracil, Cisplatinum" (1 trials) and "Abraxane" (1 trials). Other intervention names were less common.

Clinical Trials Genders at LKH Leoben


The vast majority of trials in "LKH Leoben" are 23 trials for "All" genders and 3 trials for "Female" genders.

Clinical Trials Status at LKH Leoben


Currently, there are NaN active trials in "LKH Leoben". undefined are not yet recruiting, 6 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in LKH Leoben, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in LKH Leoben, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 11Phase 3: 11Phase 2: 6Phase 2: 6Not Applicable: 2Not Applicable: 2Phase 1: 1Phase 1: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 11Completed: 11Active, not recruiting: 6Active, not recruiting: 6Recruiting: 6Recruiting: 6Unknown status: 2Unknown status: 2Terminated: 1Terminated: 1

Departments of LKH Leoben


LKH Leoben has several departments that took part in Clinical trials: "LKH Leoben, Abt. für Innere Medizin" - 5 trials, "LKH Hochsteiermark - Leoben, Abt. f. Innere Medizin, Haemato-Onkologie" - 2 trials
Departments List
Name
City
Trials